ZA96897B - Methods of inhibiting effects of IL-6. - Google Patents
Methods of inhibiting effects of IL-6.Info
- Publication number
- ZA96897B ZA96897B ZA9600897A ZA96897A ZA96897B ZA 96897 B ZA96897 B ZA 96897B ZA 9600897 A ZA9600897 A ZA 9600897A ZA 96897 A ZA96897 A ZA 96897A ZA 96897 B ZA96897 B ZA 96897B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- inhibiting effects
- inhibiting
- effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38473095A | 1995-02-06 | 1995-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA96897B true ZA96897B (en) | 1997-08-05 |
Family
ID=23518514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9600897A ZA96897B (en) | 1995-02-06 | 1996-02-05 | Methods of inhibiting effects of IL-6. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0724879A2 (xx) |
| JP (1) | JPH10513470A (xx) |
| KR (1) | KR19980701933A (xx) |
| CN (1) | CN1173819A (xx) |
| AU (1) | AU708374B2 (xx) |
| CA (1) | CA2212232A1 (xx) |
| CZ (1) | CZ246597A3 (xx) |
| FI (1) | FI973235A0 (xx) |
| HU (1) | HUP9801829A3 (xx) |
| IL (1) | IL117036A0 (xx) |
| NO (1) | NO973609L (xx) |
| WO (1) | WO1996024356A1 (xx) |
| YU (1) | YU6996A (xx) |
| ZA (1) | ZA96897B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025373A (en) * | 1997-04-22 | 2000-02-15 | Eli Lilly And Company | Methods for reducing fibrinogen |
| WO1999051587A1 (fr) * | 1998-04-01 | 1999-10-14 | Ono Pharmaceutical Co., Ltd. | Derives de thiophene condenses et medicaments contenant ceux-ci comme principe actif |
| US6960577B2 (en) | 1998-05-22 | 2005-11-01 | Eli Lilly And Company | Combination therapy for treatment of refractory depression |
| ES2207982T3 (es) * | 1998-12-30 | 2004-06-01 | Signal Pharmaceuticals, Inc. | Compuestos y metodos para la modulacion de receptores estrogenicos. |
| ES2156550B1 (es) * | 1999-04-19 | 2002-02-01 | Univ Navarra Publica | Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos. |
| CN1723013A (zh) * | 2003-01-06 | 2006-01-18 | 惠氏公司 | 雌激素受体α调节剂在治疗多发性硬化症中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| TW303299B (xx) * | 1993-07-22 | 1997-04-21 | Lilly Co Eli | |
| US5574047A (en) * | 1993-12-21 | 1996-11-12 | Eli Lilly And Company | Methods of inhibiting imperfect tissue repair |
| US5521198A (en) * | 1993-12-21 | 1996-05-28 | Eli Lilly And Company | Methods of inhibiting autoimmune diseases |
| US5708009A (en) * | 1993-12-21 | 1998-01-13 | Eli Lilly And Company | Methods of inhibiting myeloperoxidase activity |
| US5567820A (en) * | 1994-05-20 | 1996-10-22 | Eli Lilly And Company | Glucopyranoside benzothiophenes |
-
1996
- 1996-02-05 CZ CZ972465A patent/CZ246597A3/cs unknown
- 1996-02-05 HU HU9801829A patent/HUP9801829A3/hu unknown
- 1996-02-05 JP JP8524393A patent/JPH10513470A/ja active Pending
- 1996-02-05 EP EP96300767A patent/EP0724879A2/en not_active Withdrawn
- 1996-02-05 IL IL11703696A patent/IL117036A0/xx unknown
- 1996-02-05 YU YU6996A patent/YU6996A/sh unknown
- 1996-02-05 WO PCT/US1996/001621 patent/WO1996024356A1/en not_active Application Discontinuation
- 1996-02-05 CN CN96191799A patent/CN1173819A/zh active Pending
- 1996-02-05 AU AU49163/96A patent/AU708374B2/en not_active Ceased
- 1996-02-05 CA CA002212232A patent/CA2212232A1/en not_active Abandoned
- 1996-02-05 ZA ZA9600897A patent/ZA96897B/xx unknown
- 1996-02-05 KR KR1019970705330A patent/KR19980701933A/ko not_active Application Discontinuation
-
1997
- 1997-08-05 NO NO973609A patent/NO973609L/no not_active Application Discontinuation
- 1997-08-05 FI FI973235A patent/FI973235A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI973235A (fi) | 1997-08-05 |
| CA2212232A1 (en) | 1996-08-15 |
| NO973609L (no) | 1997-09-11 |
| AU708374B2 (en) | 1999-08-05 |
| AU4916396A (en) | 1996-08-27 |
| HUP9801829A2 (hu) | 1999-05-28 |
| KR19980701933A (ko) | 1998-06-25 |
| NO973609D0 (no) | 1997-08-05 |
| FI973235A0 (fi) | 1997-08-05 |
| HUP9801829A3 (en) | 1999-10-28 |
| WO1996024356A1 (en) | 1996-08-15 |
| CN1173819A (zh) | 1998-02-18 |
| EP0724879A3 (xx) | 1996-09-11 |
| EP0724879A2 (en) | 1996-08-07 |
| IL117036A0 (en) | 1996-06-18 |
| JPH10513470A (ja) | 1998-12-22 |
| MX9705940A (es) | 1997-10-31 |
| CZ246597A3 (cs) | 1998-06-17 |
| YU6996A (sh) | 1999-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0835109A4 (en) | PYRIDINONE-BASED THROMBIN INHIBITORS | |
| PL321759A1 (en) | Novel thrombosin inhibitors | |
| PL327569A1 (en) | Promedications of thrombosin inhibitors | |
| EG23871A (en) | Protein kinase c inhibitor | |
| IL122923A0 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
| EP0749067A3 (en) | optimizer | |
| PH31599A (en) | Methods of inhibiting autoimmune diseases. | |
| ZA969221B (en) | Indolealkyl derivatives of benzodioxanmethylamine. | |
| ZA965922B (en) | Preparation of N-substituted 3-hydroxypyrazoles. | |
| PH31326A (en) | Methods of inhibiting breast disorders. | |
| GB2306848B (en) | Hydrophone | |
| IL122338A0 (en) | Methods of inhibiting phagocytosis | |
| ZA964682B (en) | Methods of inhibiting melanoma. | |
| ZA96897B (en) | Methods of inhibiting effects of IL-6. | |
| ZA967282B (en) | Zwitterionic forms of trovafloxacin. | |
| GB9510563D0 (en) | Well inhibition | |
| ZA961564B (en) | Methods of inhibiting ovarian cancer. | |
| GB9514866D0 (en) | Overflow prevention plug | |
| EP0796095A4 (en) | METHOD FOR INHIBITING THE EFFECTS OF GROWTH HORMONE | |
| SG64924A1 (en) | Inhibiting photodecompostion of 3-substituted-2- oxindoles | |
| GB9722556D0 (en) | Methods | |
| AU7399298A (en) | Methods of inhibiting corrosion using N-haloazoles | |
| GB2305201B (en) | Water defence block | |
| GB2323095B (en) | Wax Deposit Inhibitors | |
| GB9516940D0 (en) | Methods |